Company Management

SPOREGEN LIMITED

Biotechnology Research London, City of, United Kingdom 4 employees

Employees: 4
Contacts: 1
Emails: 1

www.sporegen.com LinkedIn

SPOREGEN LIMITED Overview

Headquarters: London, City of, United Kingdom
Phone Number: Available in AeroLeads
Website: www.sporegen.com
Industry: Biotechnology Research
Employees: 4
Founded: 2012
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Probiotics Medical Foods Clostridium difficile Bacillus spore formers mucosal vaccines animal vaccines

About SPOREGEN LIMITED

SPOREGEN LIMITED is a biotechnology company based at The London BioScience Innovation Centre (LBIC) in London. SPOREGEN is focused on four areas. 1. Clostridium difficile: we have developed a unique prophylactic and therapeutic approach for C. difficile infection. 2. Probiotics: we identify and develop Bacillus, heat stable, spore probiotic formulations. This includes progression to GRAS status and a number of these have now been licenced including HU58 and HU36. 3. Prophylactic approaches to COVID-19 including SPOR-COV, a unique mucosal immune modulator, and SPORCOVAX, a mucosal vaccine. 4. Contracts: focusing primarily on in vivo evaluations of C. difficile interventions.